Firms Race for Hepatitis C Drugs
FEBRUARY 25, 2009
Vincent Lo Re, III, MD, MSCE, Assistant Professor of Medicine and Epidemiology, and Senior Scholar, Center for Clinical Epidemiology and Biostatistics was recently mentioned in a Wall Street Journal article about the development of therapies to combat Hepatitis C at various pharmaceutical companies.
